Search research articles
Contact Us
Filters
Showing results (141-150 of 147) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 147 results.
Nature Communications
|
November 23, 2018
Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma
Elizabeth C Randall, Kristina B Emdal, Janice K Laramy, et al.
Epilepsia
|
June 26, 2026
Acute and Long-Term EEG and seizure characteristics in new onset refractory status epilepticus (NORSE)
Kia Gilani, Aurélie Hanin, Nicolas Gaspard, et al.
Neuro-Oncology
|
May 29, 2021
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma
Bianca-Maria Marin, Kendra A Porath, Sonia Jain, et al.
Epilepsia
|
August 22, 2025
Standard complete blood count to predict long-term outcomes in febrile infection-related epilepsy syndrome (FIRES): A multicenter study
Martin Guillemaud, Aurélie Hanin, James J Riviello, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
May 7, 2025
Identification of Distinct Biological Groups of Patients With Cryptogenic NORSE via Inflammatory Profiling
Martin Guillemaud, Mario Chavez, Firas Kobeissy, et al.
Epilepsia
|
April 16, 2024
Comparative analysis of patients with new onset refractory status epilepticus preceded by fever (febrile infection-related epilepsy syndrome) versus without prior fever: An interim analysis
Anthony D Jimenez, Margaret Gopaul, Hannah Asbell, et al.
Epilepsia
|
June 5, 2024
Trends in management of patients with new-onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis
Aurelie Hanin, Anthony D Jimenez, Margaret Gopaul, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 147) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 147 results.
Nature Communications
|
November 23, 2018
Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma
Elizabeth C Randall, Kristina B Emdal, Janice K Laramy, et al.
Epilepsia
|
June 26, 2026
Acute and Long-Term EEG and seizure characteristics in new onset refractory status epilepticus (NORSE)
Kia Gilani, Aurélie Hanin, Nicolas Gaspard, et al.
Neuro-Oncology
|
May 29, 2021
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma
Bianca-Maria Marin, Kendra A Porath, Sonia Jain, et al.
Epilepsia
|
August 22, 2025
Standard complete blood count to predict long-term outcomes in febrile infection-related epilepsy syndrome (FIRES): A multicenter study
Martin Guillemaud, Aurélie Hanin, James J Riviello, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
May 7, 2025
Identification of Distinct Biological Groups of Patients With Cryptogenic NORSE via Inflammatory Profiling
Martin Guillemaud, Mario Chavez, Firas Kobeissy, et al.
Epilepsia
|
April 16, 2024
Comparative analysis of patients with new onset refractory status epilepticus preceded by fever (febrile infection-related epilepsy syndrome) versus without prior fever: An interim analysis
Anthony D Jimenez, Margaret Gopaul, Hannah Asbell, et al.
Epilepsia
|
June 5, 2024
Trends in management of patients with new-onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis
Aurelie Hanin, Anthony D Jimenez, Margaret Gopaul, et al.
Page
of 15